The Impact of Alzheimer’s

Hear three families share their stories about this devastating disease.

Learn More
Expert

Ocular Hypertension and Glaucoma

University of California, San Francisco, UCSF Medical Center
Illustration depicting pressure inside of the eye
Illustration by Bob Morreale, courtesy of BrightFocus Foundation.

Ocular hypertension is a condition in which the measured eye pressure (intraocular pressure or IOP) is consistently greater than “normal." However, there is no obvious damage to the optic nerve as detected by an eye examination, optic nerve imaging, or evidence of visual field change. In other words, there is no evidence of glaucoma yet.

In considering what constitutes ocular hypertension, it is important to recognize that “normal” eye pressure likely depends on many different factors, including age and ethnicity, as well as factors such as corneal thickness (more on that below).

In the United States, the prevalence of ocular hypertension in non-Hispanic Whites who are 40 years of age and older is 4.5 percent, and increases up to 7.7 percent in 75 to 79 year olds. In Latinos, the prevalence across ages is quite similar. Because ocular hypertension occurs typically without symptoms, a majority of people with ocular hypertension remains undiagnosed. In the Los Angeles Latino Eye Study, 75 percent of Latinos with eye pressures greater than 21 mmHg were previously undiagnosed.

Video: Ocular Hypertension

View VideoView Video

Why is Ocular Hypertension Important?

Eye pressure is one of the major risk factors for the development of glaucoma. That being said, there are also plenty of individuals who never demonstrate elevated eye pressure but do have glaucoma. This is called “normal-tension” or “low-tension” glaucoma.

What are the Risk Factors?

It is estimated that three to six million persons in the United States have ocular hypertension. These are individuals whom an eye care provider will follow closely for the development of glaucoma. The likelihood of developing glaucoma increases with the number and relative strength of risk factors.

Risk factors of ocular hypertension include:

  • higher eye pressure,
  • older age,
  • family history of glaucoma,
  • lower ocular perfusion pressure (this is related to blood pressure and eye pressure),
  • lower systemic blood pressure,
  • thinner central cornea, and
  • bleeding at the optic nerve head.

Corneal Thickness

Central corneal thickness is an independent risk factor for the development of glaucoma. The cornea is the clear “window” of the eye and whenever eye pressure is measured, the biomechanical properties of the cornea play a role in the accuracy of the measurement.

When using applanation tonometry (one of the most common forms of eye pressure measurement), eye pressure may be overestimated with thicker corneas and underestimated with thinner corneas. There has been a lot of research trying to establish the exact relationship between eye pressure as measured by various techniques and central corneal thickness, but there is no widely accepted formula to account for an individual’s central corneal thickness. However, most eye care providers would take into consideration central corneal thickness. For example, a patient with thin corneas and high eye pressure would be considered higher risk than a patient with thick corneas and high eye pressure.

Low Blood Pressure

It is interesting to note that while higher blood pressure can indeed raise eye pressure by a very small amount, lower blood pressure is actually a risk factor for the development of glaucoma. This is likely due to the fact that lower blood pressure means lower perfusion pressure and decreased blood flow to the eye and optic nerve, which is a risk factor for the development of glaucoma.

How Quickly Can Ocular Hypertension Develop Into Glaucoma?

One well done and critical study that provided important information about ocular hypertension and the development of glaucoma is the Ocular Hypertension Treatment Study (OHTS). It demonstrated that the rate of untreated ocular hypertension patients in developing glaucoma was 9.5 percent in 5 years and 22 percent at 13 years, or about 2 percent per year. With treatment, the risk of developing glaucoma was reduced by about 50 percent.

When Should Treatment Begin?

So how do we decide whether a patient with ocular hypertension should be treated? This decision is complex, and should be undertaken together by both the patient and eye doctor. The eye doctor will consider the findings of the eye exam, risk factor assessment, testing such as optic nerve imaging and visual field testing and the patient’s preferences and ability to adhere to a treatment plan. The decision to begin treatment is particularly important in the case of ocular hypertension patients or glaucoma suspects, because treatment is long-term and exposes the patient to the side effects and costs of treatment. For some patients, the eye doctor and patient will reach the conclusion that the risk of developing glaucoma is high enough to justify treatment. The OHTS study provides some guidance on this topic as those with higher eye pressures and thinner corneas were most at risk for developing glaucoma.

There are also situations that are clearer with regard to when a patient with ocular hypertension should undergo treatment. Patients who demonstrate optic nerve damage or visual field changes over time should be treated because they have likely developed early glaucoma.

The bottom line is that a patient with ocular hypertension should have long-term follow-up with their eye doctor to monitor the potential development of glaucoma or to gauge the effectiveness of treatments that are implemented.

Resources:

This content was first posted on: March 14, 2017

The information provided here is a public service of the BrightFocus Foundation and should not in any way substitute for personalized advice of a qualified healthcare professional; it is not intended to constitute medical advice. Please consult your physician for personalized medical advice. BrightFocus Foundation does not endorse any medical product, therapy, or resources mentioned or listed in this article. All medications and supplements should only be taken under medical supervision. Also, although we make every effort to keep the medical information on our website updated, we cannot guarantee that the posted information reflects the most up-to-date research.

These articles do not imply an endorsement of BrightFocus by the author or their institution, nor do they imply an endorsement of the institution or author by BrightFocus.

Some of the content may be adapted from other sources, which will be clearly identified within the article.

More Like This

  • Image provided by NeoMedix, manufacturer of Trabectome (www.trabectome.com)
    Expert

    Trabectome Surgery and Glaucoma

    Trabectome surgery, a minimally invasive glaucoma procedure, involves the use of an FDA-approved handheld device. The treatment increases the amount of fluid that drains from the eye, thereby lowering eye pressure. Learn more about this surgery and important questions to ask your doctor.

    March 18, 2019
  • A gentleman with glaucoma is talking to his pharmacist about two medications
    Expert

    Top 10 Tips for Reducing the Costs of your Glaucoma Medications

    If you or someone in your family has glaucoma, the cost of the glaucoma eye drops may be a challenge each month, especially when considering that many people are also taking medications for other chronic diseases. Since glaucoma is generally a lifelong condition, it is essential to identify a long-term strategy for treatment, and financial burden is important to consider. This article provides some tips to help you reduce the financial burden of your glaucoma treatment.

    March 13, 2019
  • Photo of a puppy with the peripheral (sides) of the image completely opaque due to glaucoma-related vision loss.
    Expert

    How Long Does it Take to Go Blind from Glaucoma?

    How quickly blindness can occur when someone has glaucoma is determined by many factors, including ones that you can control. Learn three important steps that can reduce your risk of going blind from this eye disease.

    February 19, 2019
Don't miss out.
Receive research updates, inspiring stories, and expert advice
Keep me informed about: *
Please select at least one.
You must select at least one disease category.
Please enter your first name.
Please enter your last name.